Donanemab for Alzheimer's Gets Unanimous Thumbs Up From FDA Panel

Posted in Medicine, Science on 13th Jun, 2024
by Alex Muller

If approved, donanemab will expand the first class of disease-modifying drugs, serving as the building blocks for future generations of drugs.

NHS offers first drug targeting advanced breast cancers driven by BRCA gene mutations

Posted in Medicine, Science on 26th Jan, 2024
by Alex Muller

Talazoparib (Talzenna) will become the NHS’s first targeted treatment for advanced breast cancers caused by mutations to BRCA genes

Thousands of women offered anastrozole to help prevent breast cancer

Posted in Medicine, Science on 12th Nov, 2023
by Alex Muller

Repurposing therapeutic drugs that have already been shown to be safe for prevention is an area with a lot of potential.

Study Finds Carcinogen Exposure Makes Cancer Cells More Susceptible to Immune Attack, with Implications for Treatment

Posted in Medicine on 18th Oct, 2023
by Alex Muller

The researchers hypothesized that DNA-mutating carcinogens may enhance the immune response to cancer.

Immunotherapy shows promise as a kinder first-line treatment for advanced head and neck cancers

Posted in Medicine, Science on 7th Oct, 2023
by Alex Muller

Immunotherapy can extend the response of some head and neck tumours to treatment, maintaining the anti-tumour effects and preventing them from growing or spreading for longer, a study reports.